{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:32:58Z","timestamp":1790263978554,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.medcli.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T16:13:51Z","timestamp":1543335231000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tratamiento de la telangiectasia hemorr\u00e1gica hereditaria en el paciente adulto"],"prefix":"10.1016","volume":"152","author":[{"given":"Antoni","family":"Riera-Mestre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Castellote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2018.09.015_bib0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/pmj.79.927.18","article-title":"Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century","volume":"79","author":"Begbie","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.medcli.2018.09.015_bib0310","unstructured":"Portal de informaci\u00f3n de enfermedades raras y medicamentos hu\u00e9rfanos. [consultado 13 de Jun 2018]. Disponible en: www.orpha.net"},{"key":"10.1016\/j.medcli.2018.09.015_bib0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.medcli.2018.09.015_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2015.00001","article-title":"Hereditary hemorrhagic telangiectasia: Genetics and molecular diagnostics in a new era","volume":"6","author":"McDonald","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.medcli.2018.09.015_bib0325","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1038\/ncomms13650","article-title":"PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia","volume":"7","author":"Ola","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.medcli.2018.09.015_bib0330","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCP.0000000000000472","article-title":"Systematic screening in hereditary hemorrhagic telangiectasia: A review","volume":"24","author":"Kroon","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0335","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2018.09.015_bib0340","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1523-1747.ep12555569","article-title":"Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia","volume":"95","author":"Braverman","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0345","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/ajmg.a.32243","article-title":"Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia","volume":"146","author":"Letteboer","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.medcli.2018.09.015_bib0350","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMra1607407","article-title":"Arteriovenous malformations of the brain","volume":"376","author":"Solomon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0355","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s10620-017-4719-3","article-title":"Gastrointestinal manifestations of hereditary hemorrhagic telangiectasia (HHT): A systematic review of the literature","volume":"62","author":"Jackson","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.medcli.2018.09.015_bib0360","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","article-title":"The natural history of epistaxis in hereditary hemorrhagic telangiectasia","volume":"101","author":"AAssar","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.medcli.2018.09.015_bib0365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12955-017-0586-z","article-title":"Quality of life in patients with hereditary haemorrhagic.telangiectasia (HHT)","volume":"15","author":"Zarrabeitia","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.medcli.2018.09.015_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.rce.2018.07.002","article-title":"Registro informatizado de la telangiectasia hemorr\u00e1gica hereditaria (Registro RiHHTa) en Espa\u00f1a: objetivos, m\u00e9todos y resultados preliminares","author":"Riera-Mestre","year":"2018","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.medcli.2018.09.015_bib0375","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagia telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.medcli.2018.09.015_bib0380","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-018-0850-2","article-title":"European reference Network for rare vascular diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia","volume":"13","author":"Shovlin","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2018.09.015_bib0385","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: A European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2018.09.015_bib0390","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.arcmed.2005.03.037","article-title":"Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia","volume":"36","author":"Sadick","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.medcli.2018.09.015_bib0395","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4193\/Rhino09.201","article-title":"Anti-estrogen therapy for hereditary hemorrhagic telangiectasia\u2013a long-term clinical trial","volume":"49","author":"Yaniv","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.medcli.2018.09.015_bib0400","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hed.23655","article-title":"Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial","volume":"37","author":"Riss","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.medcli.2018.09.015_bib0405","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2016.11724","article-title":"Effect of topical intranasal therapy on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia: A randomized clinical trial","volume":"316","author":"Whitehead","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2018.09.015_bib0410","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.2016.11387","article-title":"Effect of bevacizumab nasal spray on epistaxis duration in hereditary hemorrhagic telangectasia: A randomized clinical trial","volume":"316","author":"Dupuis-Girod","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2018.09.015_bib0415","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1945892418768588","article-title":"Bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: An evidence-based review","volume":"32","author":"Halderman","year":"2018","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.medcli.2018.09.015_bib0420","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2352-3026(15)00195-7","article-title":"Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: Results of a non-randomised, single-centre, phase 2 study","volume":"2","author":"Invernizzi","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0425","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0194599817700573","article-title":"Thalidomide for epistaxis in patients with hereditary hemorrhagic telangiectasia: A preliminary study","volume":"157","author":"Fang","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.medcli.2018.09.015_bib0430","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","article-title":"ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation","volume":"38","author":"Alsina-Sanch\u00eds","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0435","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9982","article-title":"Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans","volume":"8","author":"Castillo","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0440","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4193\/Rhino11.211","article-title":"Local sclerotherapy with polydocanol (Aethoxysklerol\u00ae) for the treatment of epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience","volume":"50","author":"Morais","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.medcli.2018.09.015_bib0445","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0022215100136369","article-title":"Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia","volume":"111","author":"Lund","year":"1997","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0450","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2500\/ajra.2012.26.3809","article-title":"The young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia","volume":"26","author":"Richer","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.medcli.2018.09.015_bib0455","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0028-1085093","article-title":"Hepatic vascular malformations in hereditary hemorrhagic telangiectasia","volume":"28","author":"Khalid","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.medcli.2018.09.015_bib0460","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10620-011-1585-2","article-title":"Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia","volume":"56","author":"Buscarini","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.medcli.2018.09.015_bib0465","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2007.12.022","article-title":"Liver involvement in a large cohort of patients with hereditary hemorrhagic telangietasia: Echo-color-Doppler vs multislice computed tomography study","volume":"48","author":"Buonamico","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0470","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhep.2014.02.028","article-title":"Identifying the presence of clinically significant hepatic involvement in hereditary hemorrhagic telangiectasia using a simple scoring system","volume":"61","author":"Singh","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0475","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.gastrohep.2017.03.011","article-title":"Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver","volume":"40","author":"Mart\u00edn-Llah\u00ed","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0480","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJM200009283431305","article-title":"Liver disease in patients with hereditary hemorrhagic telangiectasia","volume":"343","author":"Garcia-Tsao","year":"2000","journal-title":"New Eng J Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0485","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2006.12.008","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0490","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.diii.2014.01.023","article-title":"Comparison between Doppler ultrasonography and multiphase detector-row computed tomography in the detection of liver involvement in Rendu-Osler disease","volume":"97","author":"Cavel","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.medcli.2018.09.015_bib0495","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/MEG.0b013e32833ac4a1","article-title":"Large spectrum of liver vascular lesions including high prevalence of focal nodular hiperplasia in patients with hereditary hemorrhagic telangiectasia: The Belgian Registry base don 30 patients","volume":"22","author":"Brenard","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0500","doi-asserted-by":"crossref","first-page":"e0188943","DOI":"10.1371\/journal.pone.0188943","article-title":"Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia: a retrsopective study of 46 patients","volume":"30","author":"Guilhem","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2018.09.015_bib0505","first-page":"948","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girord","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2018.09.015_bib0510","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejvs.2015.12.020","article-title":"Clinical outcomes of patients with severe hepatic hereditary hemorrhagic telangiectasia after banding of the hepatic artery and banding\/ligation of branches of the hepatic artery","volume":"51","author":"Liu","year":"2016","journal-title":"Eur j Vasc Endovasc Sur"},{"key":"10.1016\/j.medcli.2018.09.015_bib0515","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.hpb.2017.03.005","article-title":"Liver transplantation for hereditary hemorrhagic telangiectasia: A systemic review","volume":"19","author":"Felli","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.medcli.2018.09.015_bib0520","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/liv.13187","article-title":"Hereditary hemorrhagic telangiectasia: to transplant ot not to transplant- is there a right time for liver transplantation?","volume":"36","author":"Muller","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.medcli.2018.09.015_bib0525","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jhep.2004.06.007","article-title":"Orthotopic liver transplantation and hereditary hemorrhagic telangiectasia: Do hepatic vascular malformations relapse? A long-term follow up study on two patients","volume":"41","author":"Sabba","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0530","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000479632","article-title":"The lung in hereditary hemorrhagic telangiectasia","volume":"94","author":"Dupuis-Girod","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.medcli.2018.09.015_bib0535","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.201407-1254CI","article-title":"Pulmonary arteriovenous malformations","volume":"190","author":"Shovlin","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0540","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cid\/cix373","article-title":"Cerebral abscess associated with odontogenic bacteremias hypoxemia, and iron loading in immunocompetent patients with right-to-left shunting through pulmonary arteriovenous malformations","volume":"65","author":"Boother","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2018.09.015_bib0545","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/thoraxjnl-2014-205289","article-title":"Orthodeoxia and postural orthostatic tachycardia in patients with pulmonary arteriovenous malformations: A prospective 8-year series","volume":"69","author":"Santhirapala","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.medcli.2018.09.015_bib0550","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0002-9149(91)90287-U","article-title":"Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations","volume":"68","author":"Barzilai","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0555","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1378\/chest.12-1599","article-title":"Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: A striking association","volume":"144","author":"Velthuis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.medcli.2018.09.015_bib0560","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1183\/09031936.00104309","article-title":"Graded contrast echocardiography in pulmonary arteriovenous malformations","volume":"35","author":"Parra","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medcli.2018.09.015_bib0565","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5152\/dir.2015.15262","article-title":"Persistence of pulmonary arteriovenous malformations after successful embolotherapy with Amplatzer vascular plug: Long-term results","volume":"22","author":"Abdel Aal","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.medcli.2018.09.015_bib0570","doi-asserted-by":"crossref","first-page":"e90937","DOI":"10.1371\/journal.pone.0090937","article-title":"Impact of pulmonary arteriovenous malformations on respiratory-related quality of life in patients with hereditary haemorrhagic telangiectasia","volume":"9","author":"Blivet","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2018.09.015_bib0575","first-page":"195","article-title":"Contemporary role of minimally invasive thoracic surgery in the management of pulmonary arteriovenous malformations: Report of two cases and review of the literature","volume":"8","author":"Bakhos","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.medcli.2018.09.015_bib0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1378\/chest.123.2.351","article-title":"Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations","volume":"123","author":"Lee","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.medcli.2018.09.015_bib0585","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1183\/13993003.01588-2015","article-title":"Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia","volume":"47","author":"Vorselaars","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medcli.2018.09.015_bib0590","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.201702-0267LE","article-title":"Pulmonary hypertension prevalence and prognosis in a cohort of patients with hereditary hemorrhagic telangiectasia undergoing embolization of pAVMs","volume":"196","author":"Chizinga","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2018.09.015_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018759918","article-title":"The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia","volume":"8","author":"Li","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.medcli.2018.09.015_bib0600","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09031936.00126207","article-title":"Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure","volume":"32","author":"Shovlin","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318306353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318306353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T03:07:33Z","timestamp":1605496053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775318306353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0025775318306353"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2018.09.015","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento de la telangiectasia hemorr\u00e1gica hereditaria en el paciente adulto","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}